Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F6ZS
|
|||
| Former ID |
DIB007661
|
|||
| Drug Name |
Ro-25-6833
|
|||
| Synonyms |
Ro-25-6833; 161672-76-0; Ro25-6833; RO 25-6833; CHEMBL53624; SCHEMBL7614481; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(hydroxyimino)acetyl)amino)-8-oxo-((2-oxo-1-(2,2,2-trifluoroethyl)-3-pyrrolidinylidene)methyl)-, (6R-(3(E),6a,7b(Z)))-; 3-[[(3E)-1-(2,2,2-Trifluoroethyl)-2-oxopyrrolidin-3-ylidene]methyl]-7beta-[[[(Z)-hydroxyimino](2-aminothiazol-4-yl)acetyl]amino]cepham-3-ene-4-carboxylic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Bacterial infection [ICD-11: 1A00-1C4Z; ICD-10: A00-B99] | Terminated | [1] | |
| Company |
F Hoffmann-La Roche Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H17F3N6O6S2
|
|||
| Canonical SMILES |
C1CN(C(=O)C1=CC2=C(N3C(C(C3=O)NC(=O)C(=NO)C4=CSC(=N4)N)SC2)C(=O)O)CC(F)(F)F
|
|||
| InChI |
1S/C19H17F3N6O6S2/c20-19(21,22)6-27-2-1-7(14(27)30)3-8-4-35-16-11(15(31)28(16)12(8)17(32)33)25-13(29)10(26-34)9-5-36-18(23)24-9/h3,5,11,16,34H,1-2,4,6H2,(H2,23,24)(H,25,29)(H,32,33)/b7-3+,26-10-/t11-,16-/m1/s1
|
|||
| InChIKey |
NOAJGZYUGGBORE-SUVYSZLLSA-N
|
|||
| CAS Number |
CAS 161672-76-0
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial Cell membrane (Bact CM) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006319) | |||
| REF 2 | Animal pharmacokinetics and interspecies scaling of Ro 25-6833 and related (lactamylvinyl)cephalosporins. J Pharm Sci. 1998 Apr;87(4):496-500. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.